Drug Markets/Efavirenz

Efavirenz

3 NDCs across 3 manufacturers|3 Generic,0 Brand

Efavirenz is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Sep 17, 1998, and the first generic was approved Feb 17, 2016. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Efavirenz across 11,000 claims for 1,545 beneficiaries.

Efavirenz is available as 3 NDCs from 3 manufacturers (3 generic, 0 brand), with NADAC prices from $1.35 to $1.35 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

3

competing in market

Price Spread

$1.35 – $1.35

per EA

7d Activity

30 flat

avg -2.9% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Efavirenz used to treat?

Efavirenz is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

When did Efavirenz become available as a generic?

FDA approved the first generic Efavirenz (ANDA) on Feb 17, 2016. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Efavirenz?

In 2024, Medicare Part D spent $4 million on Efavirenz across 11,000 claims for 1,545 beneficiaries.

How many Efavirenz products are on the market?

The Efavirenz drug market contains 3 NDCs from 3 manufacturers — 3 generic and 0 brand products.

What is the price range for Efavirenz?

NADAC reference prices for Efavirenz range from $1.3491 to $1.3491 per EA.

Which manufacturers make Efavirenz?

3 manufacturers list Efavirenz in NADAC. Ranked by number of NDCs, the largest are Camber Pharmaceuticals Inc. (1), Aurobindo Pharma Limited (1), Cipla USA Inc. (1).

How has the price of Efavirenz changed recently?

Over the past 7 days, 0 Efavirenz NDCs rose and 3 fell, with a market-wide average change of -2.9%.